The document explains the concept of compulsory licensing in India, detailing the legal provisions under the Indian Patent Act, 1970, which allow an individual or entity to use a patented invention after a specified period if certain conditions are met. It outlines the procedures for granting such licenses, the terms and conditions involved, and the government's role in acquiring patented inventions for public use. Additionally, it mentions India's first compulsory license granted to Natco for the production of a kidney cancer drug, highlighting its significance in addressing public health concerns.